EXHIBIT 99.4
CONSENT OF BEAR, STEARNS & CO. INC.
August 13, 2002
The Board of Directors
Pfizer Inc.
235 East 42nd Street
New York, NY 10017
We hereby consent to the inclusion of our opinion letter, dated July 13,
2002, to the board of directors of Pfizer Inc. ("Pfizer") as Annex C to this
joint proxy statement/prospectus which forms part of the Registration Statement
on Form S-4 (the "Registration Statement") relating to the proposed merger of
Pharmacia Corporation with Pfizer and to the references to such opinion in such
joint proxy statement/prospectus under the headings "Chapter One -- The
Merger -- Summary -- Opinions of Pfizer's Financial Advisors," "Chapter
One -- The Merger -- The Proposed Merger -- Background of the Merger," "Chapter
One -- The Merger -- The Proposed Merger -- Factors Considered by, and
Recommendation of, the Board of Directors of Pfizer," "Chapter One -- The
Merger -- Opinions of Financial Advisors -- Opinions of Pfizer's Financial
Advisors -- Opinion of Bear Stearns" and "Chapter One -- The Merger -- The
Merger Agreement -- Representations and Warranties." In giving such consent, we
do not admit that we come within the category of persons whose consent is
required under section 7 of the Securities Act of 1933, as amended (the
"Securities Act"), or the rules and regulations of the Securities and Exchange
Commission (the "SEC") thereunder, nor do we hereby admit that we are experts
with respect to any part of the Registration Statement within the meaning of the
term "experts" as used in the Securities Act or the rules and regulations of the
SEC thereunder.
BEAR, STEARNS & CO. INC.
By: /s/ FREDERICK A. MCCONKEY
-----------------------------------
Frederick A. McConkey
Senior Managing Director